Enterprise Financial Services Corp (EFSC)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,561
| Closed | -$206K | – | 169 |
|
|
2023
Q4 | $206K | Buy |
5,561
+32
| +0.6% | +$1.15K | 0.13% | 157 |
|
|
2023
Q3 | $200K | Buy |
+5,529
| New | +$196K | 0.14% | 150 |
|
|
2021
Q4 | – | Sell |
-52
| Closed | -$2K | – | 404 |
|
|
2021
Q3 | $2K | Sell |
52
-1,152
| -96% | -$57.9K | ﹤0.01% | 362 |
|
|
2021
Q2 | $60K | Buy |
1,204
+475
| +65% | +$22.8K | 0.01% | 348 |
|
|
2021
Q1 | $32K | Buy |
729
+85
| +13% | +$3.86K | 0.01% | 491 |
|
|
2020
Q4 | $29K | Buy |
644
+122
| +23% | +$5.6K | 0.01% | 488 |
|
|
2020
Q3 | $24K | Sell |
522
-236
| -31% | -$11.8K | 0.01% | 515 |
|
|
2020
Q2 | $39K | Buy |
758
+92
| +14% | +$4.72K | 0.01% | 419 |
|
|
2020
Q1 | $31K | Sell |
666
-207
| -24% | -$11K | 0.01% | 433 |
|
|
2019
Q4 | $51K | Buy |
873
+27
| +3% | +$1.5K | 0.01% | 409 |
|
|
2019
Q3 | $44K | Buy |
846
+96
| +13% | +$4.94K | 0.01% | 418 |
|
|
2019
Q2 | $37K | Buy |
750
+10
| +1% | +$502 | 0.01% | 464 |
|
|
2019
Q1 | $39K | Sell |
740
-98
| -12% | -$4.9K | 0.01% | 452 |
|
|
2018
Q4 | $40K | Sell |
838
-48
| -5% | -$2.36K | 0.03% | 265 |
|
|
2018
Q3 | $44K | Sell |
886
-163
| -16% | -$8.28K | 0.02% | 300 |
|
|
2018
Q2 | $53K | Hold |
1,049
| – | – | 0.03% | 280 |
|
|
2018
Q1 | $51K | Buy |
1,049
+159
| +18% | +$7.41K | 0.03% | 288 |
|
|
2017
Q4 | $39K | Sell |
890
-53
| -6% | -$2.45K | 0.02% | 326 |
|
|
2017
Q3 | $48K | Buy |
943
+141
| +18% | +$7.15K | 0.02% | 297 |
|
|
2017
Q2 | $43K | Hold |
802
| – | – | 0.02% | 307 |
|
|
2017
Q1 | $42K | Sell |
802
-80
| -9% | -$4.06K | 0.02% | 306 |
|
|
2016
Q4 | $42K | Sell |
882
-296
| -25% | -$14.6K | 0.02% | 298 |
|
|
2016
Q3 | $64K | Hold |
1,178
| – | – | 0.04% | 233 |
|
|
2016
Q2 | $64K | Hold |
1,178
| – | – | 0.04% | 222 |
|
|
2016
Q1 | $60K | Buy |
1,178
+213
| +22% | +$10.6K | 0.04% | 220 |
|
|
2015
Q4 | $49K | Sell |
965
-95
| -9% | -$4.84K | 0.03% | 248 |
|
|
2015
Q3 | $51K | Buy |
1,060
+232
| +28% | +$12.1K | 0.03% | 233 |
|
|
2015
Q2 | $43K | Sell |
828
-250
| -23% | -$14.1K | 0.03% | 261 |
|
|
2015
Q1 | $62K | Buy |
1,078
+122
| +13% | +$6.99K | 0.04% | 226 |
|
|
2014
Q4 | $51K | Sell |
956
-110
| -10% | -$6.15K | 0.03% | 254 |
|
|
2014
Q3 | $61K | Hold |
1,066
| – | – | 0.04% | 229 |
|
|
2014
Q2 | $71K | Hold |
1,066
| – | – | 0.04% | 219 |
|
|
2014
Q1 | $71K | Hold |
1,066
| – | – | 0.04% | 202 |
|
|
2013
Q4 | $71K | Hold |
1,066
| – | – | 0.04% | 205 |
|
|
2013
Q3 | $67K | Buy |
1,066
+240
| +29% | +$15.4K | 0.04% | 190 |
|
|
2013
Q2 | $52K | Buy |
+826
| New | +$52.4K | 0.04% | 199 |
|
Other funds holding GSK
JEST
Enterprise Financial Services Corp (EFSC)'s GSK Position: Q1 2024 in Review
Enterprise Financial Services Corp (EFSC) sold out of GSK (GSK) in Q1 2024, closing a stake of 5,561 shares — an estimated $206K sold.
Enterprise Financial Services Corp (EFSC) first reported a position in GSK in Q2 2013 and held it in 36 quarters. The position peaked at $206K in Q4 2023. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.
- Enterprise Financial Services Corp (EFSC) reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
- Enterprise Financial Services Corp (EFSC) sold 5,561 GSK shares in Q1 2024, an estimated $206K.
- Enterprise Financial Services Corp (EFSC) first reported a position in GSK in Q2 2013 and held it in 36 quarters.
- Enterprise Financial Services Corp (EFSC)'s GSK position peaked at $206K in Q4 2023.
- 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.
Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2024, filed 14 May 2024.